Country | Years | Physician-reported—annual % change 95% CI (annual mean number of cases) | ||||||
---|---|---|---|---|---|---|---|---|
Contact dermatitis | Allergic contact dermatitis | Irritant contact dermatitis | Asthma | Noise-induced hearing loss | Carpal tunnel syndrome | Upper limb musculoskeletal disorders | ||
Physician-reported—annual % change 95% CI (annual mean number of cases) | ||||||||
France (RNV3P) | 2001–2012 | 0.1 −1.0 to 0.7 (575) | 1.0 0.0 to 2. 0 (374) | −2.3 −3.5 to −1.0 (201) | −13.6 −14.7 to −12.4 (209) | −6.5 −7.8 to −5.0 (194) | −1.7 −3.0 to 0.3 (137) | 12.6 11.2 to 14.0 (378) |
France (MCP) | 2007–2012 | −7.5 −11.9 to −2.9 (148) | – | – | −2.6 −12.3 to 8.2 (28) | −17.0 −20.8 to −13.1 (247) | −6.5 −9.3 to −3.5 (396) | 0.3 −2.3 to 1.7 (1424) |
Italy | 2000–2010 | −7.8 −9.6 to −6.0 (171) | – | – | −2.7 −4.8 to −1.6 (41) | −5.4 −7.2 to −3.6 (1697) | 6.1 3.2 to 9.1 (256) | 14.6 7.3 to 22.4 (287) |
The Netherlands (clinical specialist) | 2001–2012 | −9.2 −11.4 to −7.0 (498) | – | – | −5.7 −13.8 to 3.3 (21) | – | – | – |
The Netherlands (OP) | 2000–2012 | −0.6 −1.9 to 0.7 (145) | – | – | −0.9 −3.7 to 2.0 (25) | 1.8 0.5 to 3.1 (1982) | 0.5 −1.5 to 2.6 (61) | −2.6 −3.2 to −2.0 (1452) |
Norway | 2010–2012 | 33.3 11.4 to 59.7 (62) | – | – | −16.5 −25.4 to −6.6 (170) | – | – | – |
UK (clinical specialist) | 2000–2012 | −3.0 −3.9 to −2.1 (780) | −6.2 −7.3 to −5.0 (409) | −0.5 −1.7 to 0.7 (475) | −7.6 −9.3 to −5.9 (115) | −20.4* −24.3 to −16.2 (110) | −6.2† −10.6 to −1.6 (40) | −6.9† −10.6 to −3.0 (157) |
UK (OP) | 2000–2012 | −6.9 −9.2 to −4.5 (90) | – | – | −7.2 −11.5 to −2.7 (22) | – | −0.6 −5.0 to 4.1 (23) | −5.4 −7.0 to −3.7 (192) |
Recognised compensation—annual % change 95% CI (annual mean number of cases) | ||||||||
Belgium | 2000–2012 | – | – | – | 2.4 0.9 to 3.9 (692) | 5.9 2.6 to 9.3 (697) | – | |
The Czech Republic | 2000–2012 | −4.7 −6.8 to −2.5 (245) | −7.7 −9.2 to −6.2 (196) | −0.5 −3.4 to 2.6 (49) | −1.7 −4.6 to 1.3 (49) | −3.8 −6.6 to −0.9 (34) | 2.9 (1.1 to 4.6) (348) | 1.9 −0.1 to 4.0 (159) |
Finland | 2005–2011 | −9.8 −12.1 to −7.4 (441) | −9.3 −11.9 to −6.6 (203) | −9.2 −11.8 to −6.6 (203) | −7.7 −17.0 to 2.7 (127) | −8.7 −13.2 to −3.9 (1026) | 3.8 −3.8 to 11.9 (24) | −16.5‡ −18.2 to −14.8 (358) |
France | 2004–2012 | −6.9 −8.0 to −6.2 (954) | −6.9 −7.8 to −6.0 (917) | −10.1 −14.1 to −5.9 (37) | −6.8 −8.4 to −5.1 (318) | −3.8 −4.7 to −2.9 (1145) | 10.5 9.6 to 11.4 (18141) | 12.0 11.1 to 12.9 (1806) |
Italy | 2000–2010 | −10.7 −11.6 to −9.8 (350) | – | – | −5.1 −7.3 to −2.8 (115) | −5.2 −8.2 to −2.0 (1429) | – | 18.3 16.3 to 20.4 (2116) |
Spain | 2000–2011 | – | – | – | −3.7 −8.4 to 1.3 (336) | 9.8 4.2 to 15.6 (766) | 3.9 1.0 to 7.0 (2300) | – |
Switzerland | 2000–2011 | −7.0 −8.1 to −5.8 (754) | −7.2 −8.8 to −5.5 (420) | −7.0 −8.6 to −5.4 (334) | −3.8 −5.6 to −2.1 (156) | 3.2 1.6 to 4.9 (514) | – | −11.5 −12.5 to −10.6 (351) |
Great Britain (UK data n/a) | 2000–2011 | −11.6 −13.7 to −9.5 (140) | – | – | −4.7 −7.7 to −1.5 (80) | −5.3 −7.8 to −2.7 (235) | −5.1 −8.7 to −1.5 (604) | – |
*UK audiologist 2000–2006.
†UK rheumatologist 2000–2009.
‡Finland ULMSD excludes shoulder problems.
MCP, Maladies à Caractère Professionnel; RR, rate ratio; ULMSD, upper limb musculoskeletal disorders.